RT Journal Article
SR Electronic
T1 The influence of calcific aortic stenosis on atrioventricular conduction: a prospective observational study and Mendelian randomization
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.08.24307094
DO 10.1101/2024.05.08.24307094
A1 Rao, Karan
A1 Ciofani, Jonathan L
A1 Han, Daniel
A1 Nazarzadeh, Milad
A1 Rahimi, Kazem
A1 Baer, Alexandra
A1 Saad, Natasha
A1 Litkouhi, Princess Neila
A1 Allahwala, Usaid
A1 Hansen, Peter
A1 Bhindi, Ravinay
YR 2024
UL http://medrxiv.org/content/early/2024/05/10/2024.05.08.24307094.abstract
AB Background Aortic stenosis (AS) may prolong atrioventricular (AV) conduction secondary to calcium infiltration of the atrioventricular-His-pathway, which is hypothesized to contribute to bradyarrhythmia and sudden cardiac death in this cohort. This study investigates the correlation between calcific AS and impaired AV conduction.Methods We performed an observational study and Mendelian randomization (MR). The observational study was a sub-analysis on AS patients undergoing transcatheter aortic valve implantation2021-2023). Regression analyses were used to assess the association between aortic valve calcium volumes with electrophysiology study derived markers of AV conduction. The primary MR analyses used European-ancestry genome-wide association studies for AS (653,867 participants,13,765 cases) and PR interval (271,570 participants). The exposure outcome was the genetic liability for AS, whilst the outcome was prolonged PR interval or AV block.Results The mean age in the observational study (n=196) was 81.8 years, 64.8% were men, and 46(23.6%) had first-degree heart block. There was no significant association between total aortic valve complex calcium volume and first-degree heart block, or with PR, AH or HV intervals. On MR, no association was found between genetic liability for AS and PR interval (beta -0.41, 95%CI -1.33-0.51, p=0.38). Additional analyses evaluating genetic liability for AS and AV block suggested a significant association on IVW analysis (OR 1.15, 95%CI 1.02-1.30, p=0.02), but this was not supported by sensitivity analyses and thus interpreted with caution.Conclusions This study found no meaningful association between aortic valve calcification and PR, AH or HV interval, challenging the hypothesis that calcific AS impairs atrioventricular conduction.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Royal North Shore Cardiology Department (Sydney, Australia). The mobile electrophysiology system (EP Perfect) was loaned by BIOTRONIK (Berlin, Germany). This is an investigator initiated and led clinical trial. K. Rao is supported by National Health and Medical Research Council (NHMRC) and Heart Research Australia (HROz) PhD Scholarships. M. N. is supported by a research fellowship from the British Heart Foundation (grant number FS/IPBSRF/22/27060). K. Rahimi reports grants outside the submitted work from the British Heart Foundation, Horizon Europe AI4HF consortium (R79992/CN001), Novo Nordisk Oxford Big Data Partnership University of Oxford, the National Institute for Health Research Oxford Biomedical Centre, Oxford Martin School and UKRI?s Global Challenge Research Fund Grant Ref: ES/P011055/1. K. Rahimi has previously received consulting fees from Medtronic CRDN, and honoraria or fees from BMJ Heart, PLoS Medicine, AstraZeneca MEA Region, Medscape and WebMD Medscape UK. All other authors declare no relevant funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by Northern Sydney Local Health District Ethics Committee.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data used in the Mendelian randomisation analyses are publicly available. Summary statistics for aortic stenosis are available from: https://doi.org/10.5281/zenodo.7505361; PR interval from: https://cvd.hugeamp.org; heart failure from: https://gwas.mrcieu.ac.uk/datasets/ebi-a-GCST90018806/; and AV block from https://r9.finngen.fi